Tirzepatide is a synthetic peptide composed of 39 amino acids. As the first dual GIP/GLP-1 receptor agonist, it has gained significant attention in the treatment of type 2 diabetes and weight management.
However, like many peptide therapeutics, Tirzepatide is prone to forming high molecular weight aggregates (HMWs) during synthesis and storage. These aggregates may form through reversible non-covalent interactions or irreversible covalent bonding between peptide chains. Regardless of the mechanism, their presence can compromise peptide stability, reduce biological activity, and potentially trigger toxicity or immunogenicity. Therefore, accurate detection and control of peptide aggregates are critical for pharmaceutical quality assurance.
SEC-UV: A Standard Method for Peptide Aggregate Analysis
Size Exclusion Chromatography coupled with UV detection (SEC-UV) has become the industry-standard technique for analyzing peptide aggregates. It offers key advantages such as:
- Simple operation
- High reproducibility
- Accurate quantification
These features make SEC-UV a reliable tool for monitoring high molecular weight impurities in peptide-based drugs.
Performance Evaluation Using BioCore SEC-120 Column
1. Analysis of Tirzepatide Injection (Reference Product)
Under standard chromatographic conditions using the BioCore SEC-120 column, Tirzepatide injection was tested. The resolution (Rs) between the monomer peak and aggregate peaks reached 1.85, indicating excellent separation performance.
2. Repeatability Test of Tirzepatide Injection
A reference formulation with a concentration of 1 mg/mL was injected consecutively six times to evaluate repeatability.
- RSD of monomer peak area: 0.51%
- Result: Fully compliant with analytical requirements (RSD < 3%)
This demonstrates strong method precision and system stability.
3. Analysis of Tirzepatide API
Using the same conditions and column, Tirzepatide API samples were analyzed.
- Resolution (Rs) between monomer and aggregates: 2.2
- Result: Clear and effective separation
This confirms the method’s suitability for detecting aggregates in raw materials.
Method Validation and Sensitivity
The study applied internationally registered standard conditions to evaluate both injection and API samples:
- Resolution (Rs > 1.8): Demonstrates excellent separation efficiency
- Repeatability (RSD = 0.51%, n=6): Meets stringent analytical standards
- Limit of Detection: At 0.5 μg/mL, signal-to-noise ratio (S/N) reached 28, exceeding the required threshold (S/N > 10)
Conclusion
The BioCore SEC-120 column combined with SEC-UV detection provides a robust, sensitive, and reliable solution for analyzing high molecular weight aggregates in Tirzepatide.
With excellent separation performance, high reproducibility, and strong sensitivity, this method effectively supports quality control, stability studies, and regulatory compliance in peptide drug development and manufacturing.
As peptide therapeutics continue to expand in the pharmaceutical market, advanced analytical techniques like SEC-UV will remain essential for ensuring drug safety, efficacy, and consistency.
